ReadMax—a novel reading and scoring approach for EGFR gene copy number to predict therapeutic benefit of erlotinib treatment in EGFR wild‐type non‐small‐cell lung cancer

Por Moecks, Joachim, Soulières, Denis, Klughammer, Barbara
Publicado no J Pathol Clin Res (2015)

Reply to Watkins and Rukazenkov (J Cell Mol Med 2010), re-Letter of Response to manuscript entitled ‘Clinical outcomes in NSCLC patients with EGFR mutations: pooled analysis’ (Paz-...

Por Paz-Ares, Luis, Moecks, Joachim, Klughammer, Barbara
Publicado em 2011

Pooled analysis of clinical outcome for EGFR TKI-treated patients with EGFR mutation-positive NSCLC

Por Paz-Ares, Luis, Soulières, Denis, Moecks, Joachim, Bara, Ilze, Mok, Tony, Klughammer, Barbara
Publicado em 2014

Clinical outcomes in non-small-cell lung cancer patients with EGFR mutations: pooled analysis

Por Paz-Ares, Luis, Soulières, Denis, Melezínek, Ivan, Moecks, Joachim, Keil, Lorenz, Mok, Tony, Rosell, Rafael, Klughammer, Barbara
Publicado em 2010